SPE Journal
Volume 14,
Number 4,
December 2009,
pp. 617-626
Summary
This paper discusses research on scale inhibition and squeeze performance in
the presence of Zn2+. Some scale inhibitors, such as
bis-hexamethylenetriamine penta(phosphonic acid), BHPMP, and polymeric
inhibitors, such as phosphinopolycarboxylate (PPCA), have poor retention
characteristics in conventional squeeze treatment, where less than 50% of the
inhibitor is retained in the formation. In this study, it was demonstrated that
more than 90% of the same scale inhibitor was retained when Zn2+ was
included in the squeeze formulation. Furthermore, Zn2+ showed
significant synergistic effect on barite scale inhibition with certain
aminopentaphosphonate scale inhibitors [BHPMP and diethylenetrimine
pentaphophonic acid (DTPMP)]. Stronger solution complexes are observed for
aminophosphonates type scale inhibitors with Zn2+ than that with
alkaline earth metal ions, such as Ca2+, Mg2+, and
Ba2+. This stronger solution complex formation with Zn2+
may be attributed to the observed enhanced inhibition efficiency. Because of
the lower solubility of Zn2+-scale inhibitor salts, Zn2+
added to the inhibitor pill significantly improves the retention of some scale
inhibitors during squeeze treatment. In this paper, the projected squeeze life
(PSL) is defined. When Zn2+ is used in the inhibitor pill, the PSL
for BHPMP is increased by a factor of 60 without significantly affecting the
cost. Simulation indicates that the squeeze life may be improved significantly
at the Guerra well if this new squeeze procedure is used.
© 2009. Society of Petroleum Engineers
View full textPDF
(
602 KB
)
History
- Original manuscript received:
10 March 2008
- Meeting paper published:
28 May 2008
- Revised manuscript received:
30 September 2008
- Manuscript approved:
9 October 2008
- Published online:
27 July 2009
- Version of record:
22 December 2009